Patent intelligence · US
US 2011142948
Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy
Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy
Patent details — US 2011142948
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jun 16, 2011
- Expiration
- Jun 11, 2031
- Applicant
- BIOLITEC INC [DE]
- CPC classes
- A61K 9/ 00 A I, A61K 9/ 14 A I, A61K 9/ 51 A I, A61K 31/ 409 A I
Quick answer
US 2011142948 (Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy) is held by BIOLITEC INC [DE]. Status: granted. Granted Jun 16, 2011. Expires Jun 11, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- BIOLITEC INC [DE]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 9/ 00 A I, A61K 9/ 14 A I, A61K 9/ 51 A I, A61K 31/ 409 A I, A61K 33/ 20 A I, A61K 41/ 00 A I
More from BIOLITEC INC [DE]
Related pharmaceutical patents in our USPTO index.
-
BR PI0714667
conjugado molecular e respectivo uso
granted -
MX 2013000877
APPLICATION OF β-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT.
granted -
US 2013041307
APPLICATION OF BETA-FUNCTIONALIZED DIHYDROXY-CHLORINS FOR PDT
granted -
WO 2013015774
DIHYDROXY-CHLORINES GLYCO-SUBSTITUÉES ET CHLORINES BÊTA-FONCTIONNALISÉES POUR THÉRAPIE ANTIMICROBIENNE PHOTODYNAMIQUE
granted -
BR PI0614453
método de redução de cululite indesejada em áreas seletivas de um organismo e mistura fotossensibilizante
granted -
US 2012263625
GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY
granted -
US 2012259187
DYNAMIC COLORECTAL PDT APPLICATION
granted -
US 2011206613
METHOD AND APPLICATION OF UNSYMMETRICALLY meso-SUBSTITUTED PORPHYRINS AND CHLORINS FOR PDT
granted
Frequently asked questions
What is US patent 2011142948?
US 2011142948 (Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy) is held by BIOLITEC INC [DE]. Status: granted. Granted Jun 16, 2011. Expires Jun 11, 2031 (5 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 2011142948?
BIOLITEC INC [DE] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.
When does US 2011142948 expire?
Our index shows an expiration date of Jun 11, 2031 (5 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.